SURVEYING IMMUNOGENICITY AND SAFETY OF INFLUENZA VACCINATION IN HEALTH CARE WORKERS AND HIV-INFECTED INDIVIDUALS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

VAZIRI S.; MOKHTARI AZAD T.; NAJAFI FARID; JANBAKHSH A.R.; AFSHARIAN MANDANA; SAYAD B.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IRANIAN JOURNAL OF CLINICAL INFECTIOUS DISEASES Year:2009 | Volume:4 | Issue:1 Page(s): 19-23

Download Full-Text

View:

302

Download:

113

Cites:

Information Journal Paper

Title

SURVEYING IMMUNOGENICITY AND SAFETY OF INFLUENZA VACCINATION IN HEALTH CARE WORKERS AND HIV-INFECTED INDIVIDUALS

Author(s)

Keywords

HIV INFECTION

HEALTH CARE WORKER

INFLUENZA VACCINE

Abstract

Background: Influenza is a world-wide public health concern. It is one of the most important viral causes of acute respiratory illness, affecting all age groups, recurring several times during a lifetime. We assessed the antibody titers after vaccination against influenza among HIV-infected patients and HEALTH CARE WORKERs (HCWs).Patients and methods: During this before-after study, the antibody responses were assessed in 60 HCW and 60 HIV infected patients vaccinated with split INFLUENZA VACCINE (influvac® 2005/2006 Solvay’s INFLUENZA VACCINEs for the influenza season 2005/2006 in the northern hemisphere).Results: Although all participants had protective antibody levels against A(H1N1), A(H3N2), and B components of trivalent INFLUENZA VACCINE (before vaccination), HIV-infected patients showed seroconversion against A(H1N1), A(H3N2), and B components in 75%, 45%, and 28.3% of cases, respectively. The corresponding values were 70%, 33.3%, and 53.3% among HCWs, respectively. There were no repots of any vaccine adverse reaction. Conclusion: A comparable rise in antibody titers against influenza antigens without any adverse reaction supports the previous recommendations for influenza vaccination. Such programs can effectively decrease the probability of influenza infection in both HCWs and HIV-infected patients who are not seriously immune compromised.

Cites

No record.

References

No record.

Cite

APA: Copy

VAZIRI, S., MOKHTARI AZAD, T., NAJAFI, FARID, JANBAKHSH, A.R., AFSHARIAN, MANDANA, & SAYAD, B.. (2009). SURVEYING IMMUNOGENICITY AND SAFETY OF INFLUENZA VACCINATION IN HEALTH CARE WORKERS AND HIV-INFECTED INDIVIDUALS. IRANIAN JOURNAL OF CLINICAL INFECTIOUS DISEASES, 4(1), 19-23. SID. https://sid.ir/paper/313495/en

Vancouver: Copy

VAZIRI S., MOKHTARI AZAD T., NAJAFI FARID, JANBAKHSH A.R., AFSHARIAN MANDANA, SAYAD B.. SURVEYING IMMUNOGENICITY AND SAFETY OF INFLUENZA VACCINATION IN HEALTH CARE WORKERS AND HIV-INFECTED INDIVIDUALS. IRANIAN JOURNAL OF CLINICAL INFECTIOUS DISEASES[Internet]. 2009;4(1):19-23. Available from: https://sid.ir/paper/313495/en

IEEE: Copy

S. VAZIRI, T. MOKHTARI AZAD, FARID NAJAFI, A.R. JANBAKHSH, MANDANA AFSHARIAN, and B. SAYAD, “SURVEYING IMMUNOGENICITY AND SAFETY OF INFLUENZA VACCINATION IN HEALTH CARE WORKERS AND HIV-INFECTED INDIVIDUALS,” IRANIAN JOURNAL OF CLINICAL INFECTIOUS DISEASES, vol. 4, no. 1, pp. 19–23, 2009, [Online]. Available: https://sid.ir/paper/313495/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops